Specify a stock or a cryptocurrency in the search bar to get a summary
Zhaoke Ophthalmology Limited
6622Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People's Republic of China, South Korea, and Hong Kong. It is developing various drugs that cover ophthalmic indications, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China. Address: No. 1 Meide 3rd Road, Guangzhou, China
Analytics
WallStreet Target Price
19.46 HKDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 6622
Dividend Analytics 6622
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 6622
Stock Valuation 6622
Financials 6622
Results | 2019 | Dynamics |